Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Prostatic Neoplasms 21 Neoplasm Metastasis 3 Sleep Initiation and Maintenance Disorders 1 Prostatic Diseases 1 Prostate Cancer Metastatic Disease 1 Neoadjuvant Therapy 1 Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) 1 Metastatic Castration-resistant Prostate Neoplasms 1 Metastatic Castration-resistant Prostate Cancer (mCRPC) 1 High Risk Prostate Cancer 1 Hematologic Neoplasms 1 Genital Diseases, Male 1 Fatigue 1 Depression 1 Adenocarcinoma 1

Interventions

Cyclophosphamide 22 fludarabine 20 venetoclax 8 Whole-Body Irradiation 8 Mycophenolic Acid 8 Standard of Care 6 Mesna 6 Melphalan 6 Azacitidine 6 fludarabine phosphate 5 Sirolimus 5 thymoglobulin 4 Thiotepa 4 Tacrolimus 4 Specimen Handling 4 Filgrastim 4 Cytarabine 4 entrectinib 3 daratumumab 3 cobimetinib 3 alectinib 3 Vemurafenib 3 Surveys and Questionnaires 3 Rituximab 3 Practice Guidelines as Topic 3 Palliative Care 3 Granulocyte Colony-Stimulating Factor 3 Busulfan 3 Bortezomib 3 Blood Specimen Collection 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Hematologic Neoplasms × apalutamide × Clear all

NCT05159245 2024-07-15

FINPROVE

Helsinki University Central Hospital

Phase 2 Recruiting

Other hematologic neoplasm

Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡